Fenton Mary Kay
Chief Financial Officer at CGEM; Officer at Talaris Therapeutics, Inc.; Chief Financial Officer at ACHILLION PHARMACEUTICALS INC
- Sold, on record
- $982k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Feb 20, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- CGEMCullinan Therapeutics, Inc.Chief Financial Officer
- Talaris Therapeutics, Inc.Officer
- ACHILLION PHARMACEUTICALS INCChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ACHILLION PHARMACEUTICALS INC88,625 shares
- CGEM4,398 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusualJan 13, 2011 2011
Sold 8,750 shares at $5.00 ($44k)
Fenton Mary Kay, SVP and CFO
Sold 40.9% of holdings ($107k position)12,625 shares leftFirst sale on recordFiling
- 2 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusualMar 30, 2011 +76 days
Sold 4,000 shares at $7.50 ($30k)
Fenton Mary Kay, SVP and CFO
Sold 31.7% of holdings ($95k position)8,625 shares leftFiling
- 3 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusualApr 6, 2011 +7 days
Sold 4,250 shares at $7.50 ($32k)
Fenton Mary Kay, SVP and CFO
Sold 49.3% of holdings ($65k position)4,375 shares leftFiling
- 4 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusualJan 10, 2012 +279 days
Sold 15,000 shares at $11.22 ($168k)
Fenton Mary Kay, SVP and CFO
Sold 100% of holdings ($168k position)0 shares left3.5x usual sizeFiling
- 5 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusualJan 23, 2015 +1109 days
Sold 13,125 shares at $16.00 ($210k)
Fenton Mary Kay, EVP and CFO
Sold 100% of holdings ($210k position)0 shares leftFirst sale on recordFiling
- 6 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusualDec 28, 2015 +339 days
Sold 43,500 shares at $10.08 ($438k)
Fenton Mary Kay, Chief Financial Officer
Sold 100% of holdings ($438k position)0 shares leftFiling
- 7 Form 144 notice Talaris Therapeutics, Inc.NoticeJul 5, 2023 +2746 days
Filed to sell 12,946 shares ($40k)
Fenton Mary Kay, Officer
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale CGEMNo planFeb 20, 2026 +961 days
Sold 4,398 shares at $13.62 ($60k)
Fenton Mary Kay, Chief Financial Officer
No 10b5-1 planSold 3.4% of holdings ($1.8M position)126,380 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Feb 23, 2026 | CGEM | Chief Financial Officer | Form 4 sale | 4,398 | $60k | 3.4% | No plan | SEC |
| Jul 5, 2023 | Jul 5, 2023 | Talaris Therapeutics, Inc. | Officer | Form 144 notice | 12,946 | $40k | Notice | SEC | |
| Dec 28, 2015 | Dec 30, 2015 | ACHILLION PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 43,500 | $438k | 100.0% | Unusual | SEC |
| Jan 23, 2015 | Jan 23, 2015 | ACHILLION PHARMACEUTICALS INC | EVP and CFO | Form 4 sale | 13,125 | $210k | 100.0% | Unusual | SEC |
| Jan 10, 2012 | Jan 11, 2012 | ACHILLION PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 15,000 | $168k | 100.0% | Unusual | SEC |
| Apr 6, 2011 | Apr 6, 2011 | ACHILLION PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 4,250 | $32k | 49.3% | Unusual | SEC |
| Mar 30, 2011 | Apr 1, 2011 | ACHILLION PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 4,000 | $30k | 31.7% | Unusual | SEC |
| Jan 13, 2011 | Jan 18, 2011 | ACHILLION PHARMACEUTICALS INC | SVP and CFO | Form 4 sale | 8,750 | $44k | 40.9% | Unusual | SEC |